Six-month extension to the New Medicine Service will help patients with long term conditions


19 / 3 / 2013 Midnight

Dean Royles, chief executive of the NHS Employers organisation, responds to the NHS Commissioning Board's agreement to extend funding for the New Medicine Service (NMS) for six months.

Mr Royles said:

"The NMS is all about reaching out into the community and working with patients at the point where they get prescriptions, to help manage their health conditions effectively. This is exactly the sort of innovation we need to see in modern healthcare.

"The NHS Employers organisation developed the NMS with the Pharmaceutical Services Negotiating Committee and continues to support its development and progress. Anecdotal feedback has been very positive and we look forward to seeing results from the evaluation of the NMS later this year."
The NHS Commissioning Board's agreement was announced today by the Pharmaceutical Services Negotiating Committee (PSNC).
The NMS was introduced from 1 October 2011. It is targeted at people with the following conditions:

  • asthma and chronic obstructive pulmonary disease (COPD)
  • type 2 diabetes
  • antiplatelet/anticoagulant therapy
  • hypertension.

The service provides support to people who are newly prescribed a medicine to manage a long-term condition, which will generally help them to appropriately improve their medication adherence. The underlying purpose of the NMS is to promote the health and well-being of patients who are prescribed new medicines for long-term conditions in order to:

  • help reduce symptoms and long term complications of the long-term condition
  • identify problems with the management of the condition and the need for further information or support.

Latest Tweets

Why Register?

Great reasons to register with NHS Employers

  • A personalised website
    Manage your profile and select topics of interest to you
  • Access your dashboard
    Bookmark useful content to help you quickly find what you're looking for
  • Get involved
    Contribute to our Talking Points discussions, comment on and rate our webpages
  • Keep up to date
    Receive the latest newsletters and media summaries

Sounds great, what next?

Register Now

Not now, I will register later

Log In